en English
af Afrikaanssq Shqipam አማርኛar العربيةhy Հայերենaz Azərbaycan dilieu Euskarabe Беларуская моваbn বাংলাbs Bosanskibg Българскиca Catalàceb Cebuanony Chichewazh-CN 简体中文zh-TW 繁體中文co Corsuhr Hrvatskics Čeština‎da Dansknl Nederlandsen Englisheo Esperantoet Eestitl Filipinofi Suomifr Françaisfy Fryskgl Galegoka ქართულიde Deutschel Ελληνικάgu ગુજરાતીht Kreyol ayisyenha Harshen Hausahaw Ōlelo Hawaiʻiiw עִבְרִיתhi हिन्दीhmn Hmonghu Magyaris Íslenskaig Igboid Bahasa Indonesiaga Gaeligeit Italianoja 日本語jw Basa Jawakn ಕನ್ನಡkk Қазақ тіліkm ភាសាខ្មែរko 한국어ku كوردی‎ky Кыргызчаlo ພາສາລາວla Latinlv Latviešu valodalt Lietuvių kalbalb Lëtzebuergeschmk Македонски јазикmg Malagasyms Bahasa Melayuml മലയാളംmt Maltesemi Te Reo Māorimr मराठीmn Монголmy ဗမာစာne नेपालीno Norsk bokmålps پښتوfa فارسیpl Polskipt Portuguêspa ਪੰਜਾਬੀro Românăru Русскийsm Samoangd Gàidhligsr Српски језикst Sesothosn Shonasd سنڌيsi සිංහලsk Slovenčinasl Slovenščinaso Afsoomaalies Españolsu Basa Sundasw Kiswahilisv Svenskatg Тоҷикӣta தமிழ்te తెలుగుth ไทยtr Türkçeuk Українськаur اردوuz O‘zbekchavi Tiếng Việtcy Cymraegxh isiXhosayi יידישyo Yorùbázu Zulu
Study Confirms Stereotactic Ablative Radiotherapy Effectiveness for Early-Stage Lung Cancer

 

According to research from a phase III randomized international study from The University of Texas MD Anderson Cancer Center, patients with operable stage I non-small cell lung cancer (NSCLC) could achieve better overall survival rates if treated with stereotactic ablative radiotherapy (SABR), also known as stereotactic body radiation therapy (SBRT), rather than the current standard […]

 

Learn More

 

 

Austin CyberKnife’s Radiation Oncologists on Studio 512

 

 

Learn More

 

 

Study Finds CT Scans for Lung Cancer Turn Up Few False-Positives

 

A study recently published in The Annals of Thoracic Surgery, the official journal of the Society of Thoracic Surgeons and the Southern Thoracic Surgical Association, found that false-positive findings for CT-based screening for lung cancer were uncommon.  The results of the study is good news because even though CT-based screening for lung cancer in long-term […]

 

Learn More

 

 

The Seton Cancer Care Lung Health Program

 

According to the American Cancer Society, lung cancer is the second most common cancer in both men and women and accounts for about 27% of all cancer related deaths.  Each year, more people die of lung cancer than of colon, breast, and prostate cancers combined.  The ACS estimates that there will be about 224,390 new […]

 

Learn More

 

 

Cancer Prevention Recommendations Infographic

 

 

Learn More

 

 

Do These Three Things to Help Prevent Cancer

 

If your New Year’s resolution to get fit and healthy is already losing steam, February, which is National Cancer Prevention Month, is a great time to give yourself a second chance.  Renew your efforts to make healthier choices by learning what you can do to help reduce your cancer risk.  The Centers for Disease Control […]

 

Learn More

 

 

Treating Cancer with Less Discomfort and Downtime

 

 

Learn More

 

 

Austin CyberKnife: Your Cancer Physicians

 

 

Learn More

 

 

Seton Cancer Program Receives 2015 Innovator Award

 

Seton Cancer Program recently received an Innovator Award from the Association of Community Cancer Centers (ACCC).  Since 2011, the ACCC Innovator Awards have honored exceptional cancer programs that advance the goal of improving cancer care access, quality, and cost-effectiveness.  The 5th annual awards were given to six cancer programs that exhibited forward-thinking strategic planning and […]

 

Learn More

 

 

Infographic: Lung Cancer

 

 

Learn More